who reports sae's and protocol deviations to the irb in a clinical trial?
Published 9 years ago • 967 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
3:30
what is a protocol deviation in a clinical trial?
-
6:35
submit protocol deviations and continuing review reports to irb's in clinical trials
-
6:50
protocol deviations in clinical research from a cra perspective
-
0:55
when to report an ae vs an sae in clinical research
-
3:53
protocol deviations at clinical research sites and how to handle them
-
20:56
protocol deviations
-
15:37
protocol deviations and what clinical research site owners need to know
-
1:29
the 6 criteria for an sae in a clinical trial
-
1:34:11
cyber incident response: plans, processes and procedures
-
1:31:58
pandemic policy panel four: covid-19 origins and the regulation of virology
-
7:38
clinical research study start up regulatory documents explained quickly!
-
3:45
protocol deviation findings and pi oversight in clinical research
-
5:47
protocol deviations and their effective, resolution, and end dates in clinical research
-
54:52
understanding reporting obligations to the irb webinar 5 13 2014 final
-
1:57
aes and saes in clinical research in under 2 minutes
-
5:41
protocol deviations: documenting, managing, and reporting
-
31:04
serious adverse event reporting in clinical trials
-
4:32
clinical research adverse event documentation
-
2:03
when is an adverse event in a clinical trial actually medical history and vice versa?
-
7:09
serious adverse events and reporting timelines to regulatory, ethics committees
-
0:55
cras and adverse event resolution during clinical research close out visits
-
2:14
safety and adverse events in clinical trials